✦ LIBER ✦

Pentoxifylline Treatment Attenuates Pulmonary Vasomotor Dysfunction in Acute Lung Injury

✍ Scribed by Brett C. Sheridan; Robert C. McIntyre Jr.; Daniel R. Meldrum; David A. Fullerton

Book ID: 115635461
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 106 KB
Volume: 71
Category: Article
ISSN: 0022-4804
DOI: 10.1006/jsre.1997.5144

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phosphodiesterase Inhibition Overcomes P

Phosphodiesterase Inhibition Overcomes Pulmonary Vasomotor Dysfunction in Acute Lung Injury

✍ Brett C. Sheridan; Robert C. McIntyre Jr.; Daniel R. Meldrum; David A. Fullerton 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 106 KB

NO Prevents Neutrophil-Mediated Pulmonar

NO Prevents Neutrophil-Mediated Pulmonary Vasomotor Dysfunction in Acute Lung Injury

✍ Randall S. Friese; David A. Fullerton; Robert C. McIntyre; Jr.; Thomas F. Rehrin 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 106 KB

The hidden pulmonary dysfunction in acut

The hidden pulmonary dysfunction in acute lung injury

✍ Göran Hedenstierna 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 49 KB

l-arginine and pentoxifylline attenuate

l-arginine and pentoxifylline attenuate endothelial dysfunction after lung reperfusion injury in the rabbit

✍ Louis Normandin; Philippe Hervé; Charles Brink; Alain R. Chapelier; Philippe G. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 531 KB

Dexamethasone treatment attenuates early

Dexamethasone treatment attenuates early seawater instillation-induced acute lung injury in rabbits

✍ Ding Xinmin; Duan Yunyou; Peng Chaosheng; Feng Huasong; Zhou pingkun; Meng Jigua 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 389 KB

Efficacy of Ibuprofen and Pentoxifylline

Efficacy of Ibuprofen and Pentoxifylline in the Treatment of Phosgene-induced Acute Lung Injury

✍ Alfred M. Sciuto; Richard R. Stotts; Holcombe H. Hurt 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 455 KB 👁 1 views

Phosgene, a highly reactive former warfare gas, is a deep lung irritant which produces adult respiratory distress syndrome (ARD.9)-like symptoms following inhalation. Death caused by phosgene involves a latent, 6-24-h, fulminating non-cardiogenic pulmonary edema. The following dose-ranging study was